Expression of Plasma Membrane Receptor Genes During Megakaryocyte Development
Overview
Molecular Biology
Affiliations
Megakaryocyte (MK) development is critically informed by plasma membrane-localized receptors that integrate a multiplicity of environmental cues. Given that the current understanding about receptors and ligands involved in megakaryocytopoiesis is based on single targets, we performed a genome-wide search to identify a plasma membrane receptome for developing MKs. We identified 40 transmembrane receptor genes as being upregulated during MK development. Seven of the 40 receptor-associated genes were selected to validate the dataset. These genes included: interleukin-9 receptor (IL9R), transforming growth factor, β receptor II (TGFBR2), interleukin-4 receptor (IL4R), colony stimulating factor-2 receptor-beta (CSFR2B), adiponectin receptor (ADIPOR2), thrombin receptor (F2R), and interleukin-21 receptor (IL21R). RNA and protein analyses confirmed their expression in primary human MKs. Matched ligands to IL9R, TGFBR2, IL4R, CSFR2B, and ADIPOR2 affected megakaryocytopoiesis. IL9 was unique in its ability to increase the number of MKs formed. In contrast, MK colony formation was inhibited by adiponectin, TGF-β, IL4, and GM-CSF. The thrombin-F2R axis affected platelet function, but not MK development, while IL21 had no apparent detectable effects. ADP-induced platelet aggregation was suppressed by IL9, TGF-β, IL4, and adiponectin. Overall, six of seven of the plasma membrane receptors were confirmed to have functional roles in MK and platelet biology. Also, results show for the first time that adiponectin plays a regulatory role in MK development. Together these data support a strong likelihood that the 40 transmembrane genes identified as being upregulated during MK development will be an important resource to the research community for deciphering the complex repertoire of environmental cues regulating megakaryocytopoiesis and/or platelet function.
Analysis of transcribed sequences from young and mature zebrafish thrombocytes.
Fallatah W, De R, Burks D, Azad R, Jagadeeswaran P PLoS One. 2022; 17(3):e0264776.
PMID: 35320267 PMC: 8942222. DOI: 10.1371/journal.pone.0264776.
Methylation of dual-specificity phosphatase 4 controls cell differentiation.
Su H, Jiang M, Senevirathne C, Aluri S, Zhang T, Guo H Cell Rep. 2021; 36(4):109421.
PMID: 34320342 PMC: 9110119. DOI: 10.1016/j.celrep.2021.109421.
iPSC diversity: A key for better use and improved targeting.
Abbonante V, Di Buduo C, Balduini A J Thromb Haemost. 2021; 19(7):1641-1643.
PMID: 34176219 PMC: 8362123. DOI: 10.1111/jth.15328.
Rivera-Munoz P, Laurent A, Siret A, Lopez C, Ignacimouttou C, Cornejo M Blood Adv. 2018; 2(13):1616-1627.
PMID: 29986854 PMC: 6039658. DOI: 10.1182/bloodadvances.2018016089.
Microvasculature-directed thrombopoiesis in a 3D in vitro marrow microenvironment.
Kotha S, Sun S, Adams A, Hayes B, Phong K, Nagao R PLoS One. 2018; 13(4):e0195082.
PMID: 29617409 PMC: 5884538. DOI: 10.1371/journal.pone.0195082.